Abstract
High expression of heat shock proteins (Hsp) in breast cancer has been closely associated with tumor cell proliferation and thus a poor clinical outcome. Quercetin, a good Hsp inhibitor as a dietary flavonoid, possesses anticarcinogenic properties. Although there are many studies on the effects of quercetin on Hsp levels in human breast cancer cells, research on elucidation of its molecular mechanism continues. Herein, we aimed to investigate the effect of quercetin on Hsp levels and whether quercetin is a suitable therapeutic for two breast cancer cell lines (MCF-7 and MDA-MB-231) representing breast tumors which differed in hormone receptor, aggressiveness and treatment responses. To examine the response to high and low doses of quercetin, the cells were treated with three doses of quercetin (10, 25 and 100 μM) determined by MTT. The effects of quercetin on Hsp levels, apoptosis and DNA damage were examined by western blot analysis, caspase activity assay, comet assay and microscopy in human breast cancer cells. Compared to MDA-MB231 cells, MCF-7 cells were more affected by quercetin treatments. Quercetin effectively suppressed the expression of Hsp27, Hsp70 and Hsp90. While quercetin did not induce DNA damage, it triggered apoptosis at high levels. Although an increase in NF-κB levels is observed in the cells exposed to quercetin, the net result is the anticancer effect in case of Hsp depletion and apoptosis induction. Taken together our findings suggested that quercetin can be an effective therapeutic agent for breast cancer therapy regardless of the presence or absence of hormone receptors.
Similar content being viewed by others
Abbreviations
- EMS:
-
Ethyl methanesulfonate
- ER:
-
Estrogen receptor
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- HER2:
-
Human epidermal growth factor receptor 2
- HSF:
-
Heat shock factor
- Hsp:
-
Heat shock protein
- IC50 :
-
The half-maximal inhibitory concentration
- NF-κB:
-
Nuclear factor kappa-B
- PARP:
-
Poly (ADP-ribose) polymerase
- PR:
-
Progesterone receptor
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
ACS (2019) Chemotherapy for Breast Cancer. https://www.cancer.org/cancer/breastcancer/treatment/chemotherapy-for-breast-cancer. Accessed 10 Aug 2019
Martin EA, Brown K, Gaskell M, Al-Azzawi F, Garner RC, Boocock DJ, Mattock E, Pring DW, Dingley K, Turteltaub KW, Smith LL, White IN (2003) Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry. Cancer Res 63:8461–8465
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A, IBIS-II investigators (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383:1041–1048. https://doi.org/10.1016/S0140-6736(13)62292-8
Vargas A, Burd R (2010) Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev 68:418–428. https://doi.org/10.1111/j.1753-4887.2010.00301.x
Önay Uçar E, Şengelen A, Mertoğlu E, Pekmez M, Arda N (2018) Suppression of HSP70 expression by quercetin and its therapeutic potential against cancer. In: Asea A, Kaur P (eds) HSP70 in human diseases and disorders, heat shock proteins. Springer, Cham, pp 361–379
Choi EJ, Bae SM, Ahn WS (2008) Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 31(10):1281–1285. https://doi.org/10.1007/s12272-001-2107-0
Murakami A, Ashida H, Tera J (2008) Multitargeted cancer prevention by quercetin. Cancer Lett 269:315–325. https://doi.org/10.1016/j.canlet.2008.03.046
Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, Lin JP, Tang NY, Chung JG, Chou MJ, Teng YH, Chen DR (2010) Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33(8):1181–1191. https://doi.org/10.1007/s12272-010-0808-y
Kumar S, Stoke J, Singh UP, Gunn KS, Acharya A, Manne U, Mishra M (2016) Targeting Hsp70: a possible therapy for cancer. Cancer Lett 374:156–166. https://doi.org/10.1016/j.canlet.2016.01.056
Kim LS, Kim JH (2011) Heat shock protein as molecular targets for breast cancer therapeutics. J Breast Cancer 14:167–174. https://doi.org/10.4048/jbc.2011.14.3.167
Şengelen A, Önay-Uçar E (2018) Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells. Cell Stress Chaperones 23:885–896. https://doi.org/10.1007/s12192-018-0896-z
Önay-Uçar E, Şengelen A (2019) Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells. Cell Stress Chaperones 24:763–775. https://doi.org/10.1007/s12192-019-01004-z
Matos CP, Adiguzel Z, Yildizhan Y, Cevatemre B, Onder TB, Cevik O, Nunes P, Ferreira LP, Carvalho MD, Campos DL, Pavan FR, Pessoa JC, Garcia MH, Tomaz AI, Correia I, Acilan C (2019) May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents? Eur J Med Chem 176:492–512. https://doi.org/10.1016/j.ejmech.2019.04.070
Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, Ikejima T (2007) P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 28:1057–1066. https://doi.org/10.1111/j.1745-7254.2007.00588.x
Dayem AA, Choi HY, Yang G-M, Kim K, Saha SK, Cho S-G (2016) The anti-cancer effect of polyphenols against breast cancer and cancer stem cells: molecular mechanisms. Nutrients 8(9):581. https://doi.org/10.3390/nu8090581
Basu P, Maier C (2018) Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives. Biomed Pharmacother 107:1648–1666. https://doi.org/10.1016/j.biopha.2018.08.100
Holliday DL, Speirs V (2011) Choosing the right cell line for breast cancer research. Breast Cancer Res 13:215. https://doi.org/10.1186/bcr2889
Yang W, Cui M, Lee J, Gong W, Wang S, Fu J, Wu G, Yan K (2016) Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism. Chin J Cancer Res 28:19–28. https://doi.org/10.3978/j.issn.1000-9604.2016.02.06
Hansen RK, Oesterreich S, Lemieux P, Sarge KD, Fuqua SA (1997) Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells. Biochem Biophys Res Commun 239:851–856. https://doi.org/10.1006/bbrc.1997.7572
Khan F, Niaz K, Maqbool F, Ismail Hassan F, Abdollahi M, Nagulapalli Venkata KC, Nabavi SM, Bishayee A (2016) Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 8(9):529. https://doi.org/10.3390/nu8090529
Chowdhury I, Tharakan B, Bhat GK (2008) Caspases - an update. Comp Biochem Physiol B 151:10–27. https://doi.org/10.1016/j.cbpb.2008.05.010
Wang KKW (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23:20–26. https://doi.org/10.1016/S0166-2236(99)01479-4
D’Amours D, Sallmann FR, Dixit VM, Poirier GG (2001) Gain-offunction of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114:3771–3778
Oeckinghaus A, Ghosh S (2009) The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034. https://doi.org/10.1101/cshperspect.a000034
Napetschnig J, Wu H (2013) Molecular basis of NF-κB signaling. Annu Rev Biophys 42:443–468. https://doi.org/10.1146/annurev-biophys-083012-130338
Wang CH, Chou PC, Chung FT, Lin HC, Huang KH, Kuo HP (2017) Heat shock protein70 is implicated in modulating NF-κB activation in alveolar macrophages of patients with active pulmonary tuberculosis. Sci Rep 7:1214. https://doi.org/10.1038/s41598-017-01405-z
Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, Takayama S, Sherman MY (2014) Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Res 74:4731–4740. https://doi.org/10.1158/0008-5472.CAN-14-0747
Kang KH, Lee KH, Kim MY, Choi KH (2001) Caspase-3-mediated cleavage of the NF-kappa B subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis. J Biol Chem 276:24638–24644. https://doi.org/10.1074/jbc.M101291200
Coiras M, Lopez-Huertas MR, Mateos E, Alcami J (2008) Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes. Retrovirology 5:109. https://doi.org/10.1186/1742-4690-5-109
Castri P, Lee Y, Ponzio T, Maric D, Spatz M, Bembry J, Hallenbeck J (2014) Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kB-dependent signaling. Biochim Biophys Acta 1843:640–651. https://doi.org/10.1016/j.bbamcr.2013.12.005
Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ (2009) Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106:73–82. https://doi.org/10.1002/jcb.21977
Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, Raghavan SC (2016) Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep 6:24049. https://doi.org/10.1038/srep24049
Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J (1999) Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26:107–116. https://doi.org/10.1016/S0891-5849(98)00167-1
Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, Ji L, Yu L (2010) Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother Pharmacol 65:277–287. https://doi.org/10.1007/s00280-009-1032-7
Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L (2011) Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol 68:1161–1172. https://doi.org/10.1007/s00280-011-1596-x
Choucroun P, Gillet D, Dorange G, Sawicki B, Dewitte JD (2001) Comet assay and early apoptosis. Mutat Res 478:89–96. https://doi.org/10.1016/S0027-5107(01)00123-3
Acknowledgements
This study was funded by The Scientific and Technological Research Council of Turkey (TUBITAK, Grant Number: 1919B011502439), Turkey.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kıyga, E., Şengelen, A., Adıgüzel, Z. et al. Investigation of the role of quercetin as a heat shock protein inhibitor on apoptosis in human breast cancer cells. Mol Biol Rep 47, 4957–4967 (2020). https://doi.org/10.1007/s11033-020-05641-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05641-x